Document Type : Original Article


1 Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Clinical Research Development Unit, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4 Department of Radiology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

5 School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

6 Psychiatry and Psychology Research Center, Tehran University of Medical Sciences, Tehran, Iran


Background: Coronavirus disease 2019 (COVID-19) is a multisystem disease, manifested by several symptoms of various degrees. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can affect the central nervous system (CNS) through several mechanisms and brain imaging plays an essential role in the diagnosis and evaluation of the neurological involvement of COVID-19. Moreover, brain imaging of patients with COVID-19 would result in a better understanding of SARS-CoV-2 neuro-pathophysiology. In this study, we evaluated the brain imaging findings of patients with COVID-19 in Shohada-e Tajrish Hospital, Tehran, Iran.
Methods: This was a single-center, retrospective, and observational study. The hospital records and chest and brain computed tomography (CT) scans of patients with confirmed COVID-19 were reviewed.
Results: 161 patients were included in this study (39.1% women, mean age: 60.84). Thirteen patients (8%) had ischemic strokes identified by brain CT. Subdural hematoma, subdural effusion, and subarachnoid hemorrhage were confirmed in three patients. Furthermore, there were four cases of intracranial hemorrhage (ICH) and intraventricular hemorrhage (IVH). Patients with and without abnormal brain CTs had similar average ages. The rate of brain CT abnormalities in both genders did not differ significantly. Moreover, abnormal brain CT was not associated with increased death rate. There was no significant difference in lung involvement (according to lung CT scan) between the two groups.
Conclusion: Our experience revealed a wide range of imaging findings in patients with COVID-19 and these findings were not associated with a more severe lung involvement or increased rate of mortality.


  1. WHO Coronavirus (COVID-19) Dashboard. WHO Coronavirus (COVID-19) Dashboard with Vaccination Data [online]. [cited 2021 Nov 22]; Available from: URL:
  2. Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol 2020; 19(9): 767-83.
  3. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708-20.
  4. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77(6): 683-90.
  5. Battaglini D, Brunetti I, Anania P, Fiaschi P, Zona G, Ball L, et al. Neurological manifestations of severe SARS-CoV-2 infection: Potential mechanisms and implications of individualized mechanical ventilation settings. Front Neurol 2020; 11: 845.
  6. Kremer S, Lersy F, Anheim M, Merdji H, Schenck M, Oesterle H, et al. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study. Neurology 2020; 95(13): e1868-e1882.
  7. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020; 191: 9-14.
  8. Chen B, Chen C, Zheng J, Li R, Xu J. Insights into neuroimaging findings of patients with coronavirus disease 2019 presenting with neurological manifestations. Front Neurol 2020; 11: 593520.
  9. Klironomos S, Tzortzakakis A, Kits A, Ohberg C, Kollia E, Ahoromazdae A, et al. Nervous system involvement in coronavirus disease 2019: Results from a retrospective consecutive neuroimaging cohort. Radiology 2020; 297(3): E324-34.
  10. Najt P, Richards HL, Fortune DG. Brain imaging in patients with COVID-19: A systematic review. Brain Behav Immun Health 2021; 16: 100290.
  11. Moonis G, Filippi CG, Kirsch CFE, Mohan S, Stein EG, Hirsch JA, et al. The spectrum of neuroimaging findings on CT and MRI in adults with COVID-19. AJR Am J Roentgenol 2021; 217(4): 959-74.
  12. Choi Y, Lee MK. Neuroimaging findings of brain MRI and CT in patients with COVID-19: A systematic review and meta-analysis. Eur J Radiol 2020; 133: 109393.
  13. Niesen M, Trotta N, Noel A, Coolen T, Fayad G, Leurkin-Sterk G, et al. Structural and metabolic brain abnormalities in COVID-19 patients with sudden loss of smell. Eur J Nucl Med Mol Imaging 2021; 48(6): 1890-901.
  14. Kas A, Soret M, Pyatigoskaya N, Habert MO, Hesters A, Le GL, et al. The cerebral network of COVID-19-related encephalopathy: A longitudinal voxel-based 18F-FDG-PET study. Eur J Nucl Med Mol Imaging 2021; 48(8): 2543-57.
  15. Lang M, Li MD, Jiang KZ, Yoon BC, Mendoza DP, Flores EJ, et al. Severity of chest imaging is correlated with risk of acute neuroimaging findings among patients with COVID-19. AJNR Am J Neuroradiol 2021; 42(5): 831-7.
  16. Mahammedi A, Ramos A, Bargallo N, Gaskill M, Kapur S, Saba L, et al. Brain and lung imaging correlation in patients with COVID-19: Could the severity of lung disease reflect the prevalence of acute abnormalities on neuroimaging? A global multicenter observational study. AJNR Am J Neuroradiol 2021; 42(6): 1008-16.
  17. Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: A systematic review and current update. Acta Neurol Scand 2020; 142(1): 14-22.
  18. Vogrig A, Gigli GL, Bna C, Morassi M. Stroke in patients with COVID-19: Clinical and neuroimaging characteristics. Neurosci Lett 2021; 743: 135564.
  19. Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, et al. COVID-19 and ischemic stroke: A systematic review and meta-summary of the literature. J Thromb Thrombolysis 2020; 50(3): 587-95.
  20. Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: A systematic review and meta-analysis. Int J Stroke 2021; 16(2): 137-49.
  21. Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. Neutrophil extracellular traps in COVID-19. JCI Insight 2020; 5(11): e138999.
  22. Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020; 382(17): e38.
  23. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18(4): 844-7.
  24. Zhang S, Zhang J, Wang C, Chen X, Zhao X, Jing H, et al. COVID-19 and ischemic stroke: Mechanisms of hypercoagulability (Review). Int J Mol Med 2021; 47(3): 21.
  25. Majmundar N, Ducruet A, Prakash T, Nanda A, Khandelwal P. Incidence, pathophysiology, and impact of coronavirus disease 2019 (COVID-19) on acute ischemic stroke. World Neurosurg 2020; 142: 523-5.
  26. Fara MG, Stein LK, Skliut M, Morgello S, Fifi JT, Dhamoon MS. Macrothrombosis and stroke in patients with mild Covid-19 infection. J Thromb Haemost 2020; 18(8): 2031-3.
  27. Gunasekaran K, Amoah K, Rajasurya V, Buscher MG. Stroke in a young COVID-19 patient. QJM 2020; 113(8): 573-4.
  28. Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol 2020; 99(6): 1205-8.
  29. Al Saiegh F, Ghosh R, Leibold A, Avery MB, Schmidt RF, Theofanis T, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry 2020; 91(8): 846-8.
  30. Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A review. JAMA Neurol 2020; 77(8): 1018-27.
  31. Radmanesh A, Derman A, Lui YW, Raz E, Loh JP, Hagiwara M, et al. COVID-19-associated Diffuse Leukoencephalopathy and Microhemorrhages. Radiology 2020; 297(1): E223-7.
  32. Dorgalaleh A. Bleeding and bleeding risk in COVID-19. Semin Thromb Hemost 2020; 46(7): 815-8.